What is Mycorena?
Mycorena, operating under the Promyc brand, is at the forefront of developing sustainable and nutritious meat alternatives. The company specializes in 100% natural fermented mycoproteins, a versatile ingredient designed for B2B clients seeking to enhance their food product lines with innovative plant-based proteins. Through a collaborative co-creation approach, Mycorena partners with businesses to craft unique food items that satisfy consumer demand for protein-rich, meat-free options. Their proprietary fermentation technology leverages locally sourced components to construct high-protein mycoprotein structures, positioning them as a key player in the alternative protein market.
How much funding has Mycorena raised?
Mycorena has raised a total of $26.8M across 1 funding round:
Series A
$26.8M
Series A (2022): $26.8M, investors not publicly disclosed
What's next for Mycorena?
The substantial enterprise-level capital raised by Mycorena signals a pivotal growth phase for the company. This strategic investment is expected to fuel further research and development into their mycoprotein fermentation processes, potentially expanding their product portfolio and market reach. The focus on B2B partnerships suggests a strategy aimed at integrating their sustainable protein solutions into a wider array of food products, thereby accelerating the adoption of meat alternatives. Mycorena's trajectory indicates a strong commitment to innovation and sustainability within the rapidly evolving food technology landscape.
See full Mycorena company page
